Search clinical trials for: Durvalumab Plus Tremelimumab
Total 5535 results
-
Samsung Medical CenterActive, not recruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Italian Network for Tumor Biotherapy FoundationAstraZenecaUnknownPeritoneal Mesothelioma | Pleural MesotheliomaItaly
-
MedImmune LLCTerminatedAdvanced Solid Tumors | Aggressive B-cell LymphomasUnited States
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
John L. Villano, MD, PhDActive, not recruitingTumor, SolidUnited States
-
Yonsei UniversityCompletedMetastatic Breast CancerKorea, Republic of
-
University of Erlangen-Nürnberg Medical SchoolCompletedLocally Advanced Head and Neck Squamous Cell CarcinomaGermany
-
Centre Georges Francois LeclercAstraZenecaCompletedColorectal Cancer MetastaticFrance
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedAdenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Metastatic Bladder Cancer | Non-Transitional Cell Carcinoma of the Urothelial Tract | Small Cell of the BladderUnited States
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
Seoul National University HospitalCompletedDurvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLCKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedMetastatic Anaplastic Thyroid CancerUnited States
-
AstraZenecaCompleted
-
Assistance Publique - Hôpitaux de ParisAstraZenecaRecruitingBCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFAFrance
-
Immunocore LtdAstraZenecaCompletedMalignant MelanomaUnited States
-
Yonsei UniversityNational Cancer Center, Korea; Samsung Medical Center; AstraZeneca; Seoul National... and other collaboratorsUnknownOvarian Cancer Stage IIIC | Ovarian Cancer Stage IVKorea, Republic of
-
MedImmune LLCCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; MedImmune LLCCompletedMetastatic Colorectal CancerUnited States
-
Universitaire Ziekenhuizen KU LeuvenAstraZeneca; European Organisation for Research and Treatment of Cancer - EORTC and other collaboratorsActive, not recruitingOral Cavity Squamous Cell CarcinomaBelgium
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
AIO-Studien-gGmbHAstraZenecaWithdrawn
-
MedImmune LLCCompletedDiffuse Large B-Cell LymphomaUnited States, France, United Kingdom, Ireland
-
ARCAGY/ GINECO GROUPAstraZenecaActive, not recruiting
-
Baylor College of MedicineDuke Cancer InstituteNot yet recruitingMesotheliomaUnited States
-
Yonsei UniversityActive, not recruitingLarynx | Stage II-IVB Operable HNSCC Oral Cavity | Hypopharynx | OropharynxKorea, Republic of
-
NSABP Foundation IncCompletedColorectal Cancer MetastaticUnited States
-
AstraZenecaCompletedAdvanced Solid TumorsJapan, Korea, Republic of, Taiwan
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Spain, Canada, France, Korea, Republic of, Israel, Netherlands, United Kingdom
-
University of CologneAstraZenecaActive, not recruiting
-
AstraZenecaActive, not recruitingHepatocellular CarcinomaUnited States, Canada, Brazil, France, Italy, Russian Federation, Spain, Vietnam, Korea, Republic of, China, Germany, Ukraine, Japan, Hong Kong, Taiwan, India, Thailand
-
Centre Georges Francois LeclercAstraZenecaActive, not recruiting
-
Enrico De ToniRecruiting
-
Nordic Society of Gynaecological Oncology - Clinical...European Network of Gynaecological Oncological Trial Groups (ENGOT); Gynecologic...Completed
-
Yonsei UniversitySamsung Medical Center; AstraZeneca; Seoul National University Hospital; Korean... and other collaboratorsRecruitingPlatinum-resistant Recurrent Ovarian CancerKorea, Republic of
-
M.D. Anderson Cancer CenterMedImmune LLCActive, not recruitingAdvanced and/or Metastatic SarcomaUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...AstraZenecaTerminated
-
Asan Medical CenterSeoul National University Bundang Hospital; Hallym University Medical CenterCompletedMetastatic Gastric CancerKorea, Republic of
-
AstraZenecaMedImmune LLCActive, not recruitingAdvanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and NeckSpain, United States, Belgium, Germany, United Kingdom, Italy
-
Samsung Medical CenterUnknownEsophageal Squamous Cell CarcinomaKorea, Republic of
-
Tianjin Medical University Cancer Institute and...RecruitingUnrescetable Hepatocellular CarcinomaChina
-
Yale UniversityCompletedBreast NeoplasmsUnited States
-
Baylor College of MedicineCompletedMesotheliomaUnited States
-
MedImmune LLCCompletedGastric or Gastroesophageal Junction AdenocarcinomaCanada, United States, Taiwan, Korea, Republic of, Japan, Singapore
-
AstraZenecaRecruitingAdvanced Hepatocellular CarcinomaKorea, Republic of, Italy, Spain, Vietnam, Germany, France, Japan, United States, Hong Kong, Singapore
-
AstraZenecaApproved for marketing
-
AstraZenecaRecruiting
-
Gruppo Oncologico del Nord-OvestRecruitingGastric Cancer | Microsatellite InstabilityItaly
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruitingProstate CancerCanada
-
Grupo Espanol de Tumores NeuroendocrinosMFARActive, not recruitingMetastatic Thyroid Cancer | Metastatic Thyroid Papillary Carcinoma | Metastatic Thyroid Follicular CarcinomaSpain
-
Centre hospitalier de l'Université de Montréal...AstraZenecaActive, not recruitingHead and Neck Squamous Cell Carcinoma | Metastatic Squamous Cell CarcinomaCanada